Bill Gates recently posed five questions about AI and its potential to improve innovation in healthcare in his annual letter. Christopher Gannatti takes a look at each question and then highlights a WisdomTree strategy that focuses on the biotechnology sphere.
Read the article
The technologies of the AI, genetics and biotechnology revolutions tend to overlap, continuously accelerating innovation and impact. These impacts are being seen in many different sectors, including Health Care. Christopher Gannatti highlights an example of how megatrends can collide.
Read the article
Biotech stocks have been underperforming for three years, but could a recent breakthrough in CRISPR therapy change the tide? Christopher Gannatti explores potential opportunities and how to invest.
Read the article
We recently spoke with Jamie Metzl, Founder and Chair of One Shared World, on how the coming decades could be impacted by the BioRevolution. Christopher Gannatti provides a recap of the discussion, which covered aspect of human development and generative artificial intelligence.
Read the article
Humans have been innovating as long as we’ve been around, but the pace of our innovation is now accelerating rapidly, especially within artificial intelligence and biology. Christopher Gannatti and Jamie Metzl outline five applications of the artificial intelligence revolution and the BioRevolution.
Read the article
Due to the Russia/Ukraine conflict and subsequent drought conditions, 2022 has been a difficult year for European agriculture. Christopher Gannatti discusses genetically modified crops and how this BioRevolutionary solution could help increase yields in a time of high inflation.
Read the article
